FDA Aims to Speed Modernization in Response to Infant Formula Shortage Crisis
In the wake of the national infant formula shortage, officials from the Food and Drug Administration are taking a harder look at the agency’s technology and processes — and finding that enterprise modernization is not moving fast enough. Due to product recalls and supply chain slowdowns, infant formula has been scarce and in high demand […] More